DE69125939T2 - N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung - Google Patents

N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung

Info

Publication number
DE69125939T2
DE69125939T2 DE69125939T DE69125939T DE69125939T2 DE 69125939 T2 DE69125939 T2 DE 69125939T2 DE 69125939 T DE69125939 T DE 69125939T DE 69125939 T DE69125939 T DE 69125939T DE 69125939 T2 DE69125939 T2 DE 69125939T2
Authority
DE
Germany
Prior art keywords
gly
complex
group
radical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69125939T
Other languages
German (de)
English (en)
Other versions
DE69125939D1 (de
Inventor
Katsutoshi Nara-Shi Nara 631 Aono
Kazuhiro 5-6-6 Matsugaoka Chiba 274 Inoue
Teruomi 6-89-104 Shinmatsudo Chiba 270 Ito
Satoshi 8-5-18 Waseda Saitama 341 Okuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Delivery System Institute Ltd
Original Assignee
Drug Delivery System Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery System Institute Ltd filed Critical Drug Delivery System Institute Ltd
Publication of DE69125939D1 publication Critical patent/DE69125939D1/de
Application granted granted Critical
Publication of DE69125939T2 publication Critical patent/DE69125939T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69125939T 1990-08-17 1991-08-16 N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung Expired - Fee Related DE69125939T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21580390 1990-08-17
PCT/JP1991/001101 WO1992003480A1 (en) 1990-08-17 1991-08-16 N-acetylcarboxymethylchitosan derivative and production thereof

Publications (2)

Publication Number Publication Date
DE69125939D1 DE69125939D1 (de) 1997-06-05
DE69125939T2 true DE69125939T2 (de) 1997-11-20

Family

ID=16678514

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125939T Expired - Fee Related DE69125939T2 (de) 1990-08-17 1991-08-16 N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung

Country Status (10)

Country Link
US (1) US5463022A (enExample)
EP (1) EP0544000B1 (enExample)
JP (1) JPH0742324B2 (enExample)
AT (1) ATE152455T1 (enExample)
CA (1) CA2089519C (enExample)
DE (1) DE69125939T2 (enExample)
DK (1) DK0544000T3 (enExample)
ES (1) ES2101750T3 (enExample)
GR (1) GR3023512T3 (enExample)
WO (1) WO1992003480A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149867T3 (es) * 1993-02-26 2000-11-16 Drug Delivery System Inst Ltd Derivados de polisacaridos y soportes para farmacos.
DE4314407A1 (de) * 1993-05-03 1994-11-10 Zuckerindustrie Verein 3-(Aminoacyl-amino)-saccharide und Verfahren zu ihrer Herstellung
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US5665702A (en) * 1995-06-06 1997-09-09 Biomeasure Incorporated Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US6479457B2 (en) 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
AU4381197A (en) * 1996-09-18 1998-04-14 Chicura Cooperatie U.A. Chitosan derivatives for treating malignant tumours
US6395255B1 (en) * 1998-06-15 2002-05-28 Thomas Jefferson University Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
WO2003006526A1 (en) * 2001-07-10 2003-01-23 Kureha Chemical Industry Company, Limited Polyester production process and reactor apparatus
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
AU2003210454A1 (en) * 2002-01-08 2003-07-24 New River Pharmaceuticals, Inc. Dendritic encapsulation of active agents
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps
US8133881B2 (en) 2003-01-13 2012-03-13 Shire Llc Carbohydrate conjugates to prevent abuse of controlled substances
EP1694712A1 (en) 2003-12-04 2006-08-30 University of Utah Research Foundation Modified macromolecules and methods of making and using thereof
US20090036553A1 (en) * 2004-07-08 2009-02-05 Shire Llc Dendritic encapsulation of active agents
AU2006204045B2 (en) * 2005-01-05 2010-10-14 Board Of Regents, The University Of Texas System Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
AU2008219065B2 (en) 2007-02-19 2014-01-30 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
GB0915449D0 (en) * 2009-09-04 2009-10-07 Univ Robert Gordon Composition
BR112012025844A2 (pt) 2010-04-15 2017-07-18 Marine Polymer Tech Inc uso de nanofibras snag
CA2832859C (en) 2011-04-15 2020-06-16 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
WO2013052012A1 (en) * 2011-10-03 2013-04-11 Nanyang Technological University Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity
JP6026192B2 (ja) * 2012-09-18 2016-11-16 川研ファインケミカル株式会社 カルボキシメチルキトサンアセテート化合物、その製造方法及び化粧料
EP3006047B1 (en) * 2013-06-06 2019-08-07 Toppan Printing Co., Ltd. Needle body
WO2025123114A1 (pt) * 2023-12-15 2025-06-19 Chemyunion Ltda Composição cosmética, cosmecêutica e/ou farmacêutica, usos e métodos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3223423A1 (de) * 1982-06-23 1983-12-29 Wella Ag, 6100 Darmstadt Kosmetische mittel auf der basis von chitosanderivaten, neue chitosanderivate sowie verfahren zur herstellung dieser derivate
US4760135A (en) * 1984-09-06 1988-07-26 University Of Kentucky Research Foundation Phloretin and phlorizin derivative containing compounds
JPS61133232A (ja) * 1984-12-03 1986-06-20 Agency Of Ind Science & Technol アミノ酸又はその重合体の結合した多糖複合体の製法
US4619995A (en) * 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
JPS6270401A (ja) * 1985-09-24 1987-03-31 Fuji Boseki Kk カルボキシアルキルキトサン粒状体の製造方法
JPH0613453B2 (ja) * 1985-10-03 1994-02-23 株式会社メニコン 前眼部手術用の前房注入剤
JPH01252605A (ja) * 1988-04-01 1989-10-09 Ihara Chem Ind Co Ltd ５−フルオロウラシル担持キトサン
JPH01252604A (ja) * 1988-04-01 1989-10-09 Ihara Chem Ind Co Ltd ５−フルオロウラシル担持体
JPH01252603A (ja) * 1988-04-01 1989-10-09 Ihara Chem Ind Co Ltd ５−フルオロウラシル担持体
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici

Also Published As

Publication number Publication date
EP0544000A1 (en) 1993-06-02
GR3023512T3 (en) 1997-08-29
CA2089519A1 (en) 1992-02-18
EP0544000A4 (en) 1993-08-04
JPH0742324B2 (ja) 1995-05-10
CA2089519C (en) 2000-01-11
EP0544000B1 (en) 1997-05-02
ES2101750T3 (es) 1997-07-16
WO1992003480A1 (en) 1992-03-05
US5463022A (en) 1995-10-31
DE69125939D1 (de) 1997-06-05
DK0544000T3 (da) 1997-11-03
JPH0742324B1 (enExample) 1995-05-10
ATE152455T1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
DE69125939T2 (de) N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung
DE69730352T2 (de) Verfahren zur herstellung eines arzneimittelkomplexes
DE69830326T2 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
DE68917009T2 (de) Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften.
DE69425464T2 (de) Polysaccharidderivat und wirkstoffträger
DE60025328T3 (de) Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten
DE69417035T2 (de) Heparinderivate mit antimetastatischer wirkung
DE69935982T2 (de) Lineare cyclodextrincopolymere
DE69629114T2 (de) Ionisches molekularkonjugat von n-acylierten poly(2-amino-2deoxy-d-glucose) und polypeptide-derivaten
DE69529288T2 (de) Wasserlösliche polyen-konjugate
DE69903329T2 (de) Verfahren zur herstellung einer eisen-dextran verbindung
DE3486341T2 (de) Derivate von Dextran mit antikoagulierenden und antikomplementären Eigenschaften, ihre Herstellung und ihre biologischen Anwendungen.
DE2433883C2 (de) Verwendung von physiologisch aktiven Polypeptiden
DE69221252T2 (de) Lipophile Zusammensetzungen von Oligosaccharid-Antibiotikasalzen
DE69722434T2 (de) Buttersäure-ester mit antiproliferativer wirkung und diese enthaltende pharmazeutische zusammensetzungen
DE68916878T2 (de) Selektiv O-acylierte Glycosaminoglykane.
DE60113398T2 (de) Polysaccharidester von n-derivaten der glutaminsäure
DE69831805T2 (de) Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung
DE2659808C3 (de) Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE69125595T2 (de) Kombination von hyaluronsäure mit einem medizinischen bestandteil, und seine herstellung
DE69935526T2 (de) Supramolekulare komplexe enthaltende arzneimittel
EP1567558A2 (de) Aldonsäure-ester, verfahren zu ihrer herstellung und verfahren zur herstellung von mit polysacchariden oder polysaccharid-derivaten an freien aminogruppen gekoppelten pharmazeutischen wirkstoffen
DE69225542T2 (de) Carboxymethylmannoglukan und derivate davon
DE69833487T2 (de) Polymer-wirkstoff-konjugate zur behandlung von krebs
DE68904617T2 (de) Jodhaltige polymere mit skeletten von dextran, verfahren zu ihrer herstellung und ihre verwendungen als kontrastmittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee